Future perspectives for optimizing oral antiplatelet therapy

Cerebrovascular Diseases

Volumn 11, Issue SUPPL. 2, 2001, Pages 23-28

  Easton, J Donald ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Antiplatelet therapy; Aspirin; Clopidogrel; Dipyridamole; Glycoprotein IIb IIIa receptor antagonist

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR ANTAGONIST; ORBOFIBAN; PLACEBO; SIBRAFIBAN; XEMILOFIBAN;

ATHEROSCLEROSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; STROKE; THROMBOCYTE ACTIVATION; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS;

ADMINISTRATION, ORAL; ANIMALS; ARTERIOSCLEROSIS; CEREBROVASCULAR ACCIDENT; FORECASTING; HUMANS; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 0035054552     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049141     Document Type: Conference Paper

References (21)

1. Antiplatelet therapy
2. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis
3. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates
4. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit
5. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS)
6. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
7. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet in unplanned and elective coronary stenting: The Full Anticoagulation versus Aspirin plus Ticlopidine (FANTASTIC) study
8. A clinical trial comparing three antithrombotic-drug regimes after coronary-artery stenting
9. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS)
10. Clopidogrel reduces major adverse cardiac events after stenting compared with ticlopidine
11. Variations between countries in invasive cardiac procedures and outcome in patients with suspected unstable angina or myocardial infarction without initial ST elevation
12. Secondary prevention of small subcortical strokes (SPS3) pilot study
13. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
14. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial
15. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization: Evaluation of oral xemilofiban in controlling thrombotic events
16. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: A randomised trial
17. Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: A meta-analysis of phase III multi-center randomized trials
18. Signalling through platelet integrin alpha IIb beta 3: Inside-out, outside-in, and sideways
19. European Stroke Prevention Study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
20. Design of ESPRIT: An international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin